跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 乾閔
教授
,
神經外科
合聘教授
,
神經醫學博士學位學程
主治醫師
,
衛生福利部雙和醫院
成員
,
臺北神經醫學中心
https://orcid.org/0000-0001-5404-0145
電子郵件
m513092004
tmu.edu
tw
h-index
1219
引文
22
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2004
2024
每年研究成果
概覽
指紋
網路
專案
(8)
研究成果
(75)
資料集
(5)
類似的個人檔案
(6)
指紋
查看啟用 Chien-Min Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
77%
Traumatic Brain Injury
70%
Malignant Neoplasm
68%
Temozolomide
44%
Neoplasm
36%
Nerve Growth Factor
24%
Parkinson's Disease
23%
Oxidopamine
22%
microRNA
21%
Injury
19%
STAT3 Protein
19%
Chemotherapy
18%
Glasgow Coma Scale
17%
Disease
17%
Drug Resistance
16%
Sleep Disorder
15%
Carcinogenesis
14%
Carcinogenicity
12%
Neuroblastoma
12%
Neuroprotective Agent
12%
Tumor Microenvironment
12%
Cisplatin
11%
Glasgow Outcome Scale
11%
Breast Cancer
11%
Mouse
10%
Glioma
9%
Kudzu
9%
Optical Imaging
9%
Chalcone
9%
microRNA 205
9%
microRNA 200c
9%
Clinical Trial
9%
Phosphotransferase
9%
Hydroxamic Acid
9%
Mevinolin
9%
Monascus
9%
Red Yeast Rice
9%
Ovary Cancer
9%
Telmisartan
9%
Uncaria
9%
Dizziness
9%
Antrodia camphorata
9%
Deubiquitinase
9%
Brain Hematoma
9%
Acoustic Neuroma
9%
Acalabrutinib
9%
Pacritinib
9%
Rapamycin
9%
Pancreas Cancer
9%
Apolipoprotein E
9%
Neuroscience
Neurotrauma
100%
Traumatic Brain Injury
100%
Stem Cell
48%
Temozolomide
30%
Acoustic Neuroma
29%
Glioblastoma Multiforme
23%
Heart Rate Variability
19%
Spinal Cord Injury
19%
Neurofibromatosis Type II
19%
Cerebral Hemorrhage
19%
Sensation of Hearing
18%
Cell Line
18%
Brain Tumor
16%
In Vitro
16%
Sleep Quality
14%
Hematoma
14%
Glial Cells
13%
Sleep Disorder
12%
Drug Resistance
11%
In Vivo
10%
CD133
9%
Mir-205
9%
Factor X
9%
Interleukin 10
9%
Glasgow Coma Scale
9%
Adverse Effect
9%
Apolipoprotein E
9%
NADPH Oxidase
9%
Kinase
9%
Dopaminergic Neuron
9%
Heat Shock Protein 20
9%
Oxidopamine
9%
Acid-Sensing Ion Channel
9%
Deubiquitinase
9%
Telmisartan
9%
Dopaminergic
9%
Cerebral Perfusion Pressure
9%
Ferroptosis
9%
Cleft
9%
Dysautonomia
9%
Brain-Derived Neurotrophic Factor
9%
DNA Repair
9%
Growth Factor
9%
Hyperbaric Medicine
9%
Optical Imaging
9%
Hyaluronic Acid
9%
Arachnoid Cyst
9%
Ubiquitin
9%
Epidermal Growth Factor Receptor
9%
Gliosis
9%
Medicine and Dentistry
Neoplasm
47%
Traumatic Brain Injury
42%
Stereotactic Radiosurgery
39%
Glioblastoma
32%
Cyberknife
32%
Ganglioglioma
29%
Neurofibromatosis Type II
29%
Vestibular Schwannoma
29%
Symptom
22%
Stem Cell
21%
Temozolomide
21%
Syringomyelia
19%
Glioma Stem Cell
19%
Disease
17%
Survival Rate
16%
Bleeding
15%
Surgery
15%
Infection
14%
Injury
14%
Drug Resistance
13%
Intracranial Pressure
13%
Carcinogenesis
13%
Odds Ratio
13%
Ibrutinib
13%
Artificial Respiration
13%
Quality of Life
11%
Spinal Cord Lesion
11%
Brain Tissue
10%
Neurosurgery
10%
External Ventricular Drain
10%
Bruton Tyrosine Kinase
10%
Bruton Tyrosine Kinase Inhibitor
10%
Recurrence Risk
10%
Phosphotransferase
9%
Hindbrain
9%
Restylane
9%
Thrombocyte Rich Plasma
9%
Respiratory Care
9%
Rapamycin
9%
Sleep Quality
9%
Acalabrutinib
9%
DNA Repair
9%
Hemodialysis
9%
Prognostic Factor
9%
Case-Control Study
9%
Gene Transfer
9%
Vascular Amyloidosis
9%
Optical Imaging
9%
Ganglioneuroblastoma
9%
Analgesia
9%
